Heterogeneous nuclear ribonucleoprotein A2/B1 in association with hTERT is a potential biomarker for hepatocellular carcinoma

Liver International

Volumn 32, Issue 7, 2012, Pages 1146-1155

  Mizuno, Hideki ^a   Honda, Masao ^a   Shirasaki, Takayoshi ^a   Yamashita, Taro ^a   Yamashita, Tatsuya ^a   Mizukoshi, Eishiro ^a   Kaneko, Shuichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

HCC; HnRNP A2 B1; hTERT

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2; PROTEIN HYDROLYSATE; SMALL INTERFERING RNA; TELOMERASE REVERSE TRANSCRIPTASE; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CYTOPLASM; ENZYME ACTIVITY; FEMALE; FRACTIONATION; GEL FILTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; TANDEM MASS SPECTROMETRY;

CARCINOMA, HEPATOCELLULAR; FEMALE; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RNA, SMALL INTERFERING; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 84863508419     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2012.02778.x     Document Type: Article

References (36)

1. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002; 31: 339-46.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA Cancer J Clin 2005; 55: 74-108.
3. de Lange T. Ending up with right partner. Nature 1998; 392: 753-54.
4. Blackburn EH. Telomere states and cell fates. Nature 2000; 408: 53-6.
5. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279: 349-52.
6. Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science 1995; 269: 1236-41.
7. Weinrich SL, Pruzan R, Ma L, et al. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet 1997; 17: 498-502.
8. de Lange T. Protection of mammalian telomerase. Oncogene 2002; 21: 532-40.
9. Yan P, Benhattar J, Seelentag W, Stehle JC, Bosman FT. Immunohistochemical localization of hTERT protein in human tissues. Histochem Cell Biol 2004; 121: 391-7.
10. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.
11. Shirota Y, Kaneko S, Honda M, Kawai FH, Kobayashi K. Identification of differntially expressed genes in hepatocellular carcinoma with cDNA microarrays. Hepatology 2001; 33: 832-40.
12. Mizuno H, Khurts S, Seki T, et al. Human telomerase exists in two distinct active complexes In Vivo. J Biochem 2007; 141: 641-52.
13. Masutomi K, Yu EY, Khurts S, et al. Telomerase maintains telomere structure in normal human cells. Cell 2003; 114: 241-53.
14. Kim SY, Lee PY, Shin HJ, et al. Proteomic analysis of liver tissue from HBx-transgenic mice at early stages of hepatocarcinogenesis. Proteomic 2009; 22: 5056-66.
15. Sun W, Xing B, Sun Y, et al. Proteomic analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis. Mol Cell Proteomics 2007; 6: 1798-808.
16. Mohammad HS, Kurikihchi K, Yoneyama H, et al. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma. Int J Oncol 2008; 33: 1157-63.
17. Liang CRM, Leow CK, Neo JCH, et al. Proteomic analysis of human hepatocellular carcinoma tissues by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 2005; 5: 2258-71.
18. Na K, Lee EY, Lee HJ, et al. Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinoma. Proteomics 2009; 9: 3989-99.
19. Goldenberg D, Ayesh S, Schneider T, et al. Analysis of differentially expressed gnes in hepatocellular carcinoma. Mol Carcinog 2002; 33: 113-24.
20. Yokoyama Y, Kuramitsu Y, Takashima M, et al. Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus. Proteomics 2004; 4: 2111-6.
21. Zhou J, Mulshine JL, Unsworth EJ, et al. Purification and characterization of a protein that permits early detection of lung cancer Identification of heterogeneous nuclear ribonucleoprotein-A2/B1 as the antigen for monoclonal antibody 703D4. J Biol Chem 1996; 271: 10760-6.
22. Jing GJ, Xu DH, Shi SL, et al. Aberrant expression and localization of hnRNP-A2/B1 is a common event in human gastric adenocarcinoma. J Gastroenterol Hepatol 2011; 26: 108-15.
23. Marrero JA. Screening tests for hepatocellular carcinoma. Clin Liver Dis 2005; 9: 235-51.
24. Celis JE, Gromov P. Proteomics in translational cancer research: toward an integrated approach. Cancer Cell 2003; 3: 9-15.
25. Kawada N. Cancer serum proteomics in gastroenterology. Gastroenterology 2006; 130: 1917-19.
26. Mayeda A, Munroe S, Caveres J, Krainer A. Function of conserved domains of hnRNP A1 and other hnRNP A/B proteins. EMBO J 1994; 13: 5483-95.
27. Abdul-Manan N, Williams K. hnRNP A1 binds promiscuously to oligoribonucleotids: utilization of random and homo-oligonucleotides to discriminate sequence from base-specific binding. Nucleic Acids Res 1996; 24: 4063-70.
28. Munro TP, Magee RJ, Kidd GJ, et al. Mutational analysis of a heterogeneous nuclear ribonucleoprotein A2 response element for RNA trafficking. J Biol Chem 1999; 274: 34389-95.
29. Hamilton BJ, Nagy E, Malterg JS, Arrick BA, Rigby WFC. Association of heterogeneous nuclear ribonucleoprotein A1 and C proteins with reiterated AUUUA sequences. J Biol Chem 1993; 268: 8881-7.
30. Hamilton BJ, Burns CM, Nichols RC, Rigby WFC. Modulation of AUUUA response element binding by heterogeneous nuclear ribonucleoprotein A1 in human T lymphocytes. J Biol Chem 1997; 274: 34389-95.
31. Kim MJ, Lyndal W, Derek DK, et al. hnRNP A2, a potential ssDNA/RNA molecular adapter at the telomere. Nuleic Acids Res 2005; 33: 486-96.
32. Kamma H, Fujimoto M, Fujiwara M, et al. Interaction of hnRNP A2/B1 isoforms with telomeric ssDNA and the in Vitro function. Biochem Biophys Res Commun 2001; 280: 625-30.
33. Holt SE, Aisner DL, Baur J, et al. Functional requirement of p23 and Hsp90 in telomerase complexes. Genes Dev 1999; 13: 817-26.
34. Nakielny S, Dreyfuss G. Nuclear export of proteins and RNAs. Curr Opin Cell Biol 1997; 9: 420-29.
35. Khurts S, Masutomi K, Delgermaa L, et al. Nucleolin interacts with telomerase. J Biol Chem 2004; 279: 51508-15.
36. Cui H, Wu F, Sun Y, Fan G, Wang Q. Up-regulation and subcellular localization of hnRNP A2/B1 in the development of hepatocellular carcinoma. BMC cancer 2010; 10: 356-69.